Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Morgenroth · SciRah

Researcher profile · Semantic Scholar

L. Morgenroth

Share profile

L. Morgenroth — researcher profile on SciRah

h-index: 18
Works: 39
Citations: 1,400

Most-cited papers

Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
P. Clemens, V. Rao, A. Connolly, A. Harper +9 more
2020JAMA Neurology197 citations Open access
Semantic Scholar
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study
L. Bello, H. Gordish-Dressman, L. Morgenroth, E. Henricson +4 more
2015Neurology181 citations Open access
Semantic Scholar
DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study
L. Bello, L. Morgenroth, H. Gordish-Dressman, E. Hoffman +2 more
2016Neurology151 citations Open access
Semantic Scholar
Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study
L. Bello, A. Kesari, H. Gordish-Dressman, A. Cnaan +7 more
2015Annals of Neurology107 citations Open access
Semantic Scholar
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
E. Mercuri, F. Muntoni, A. N. Osorio, M. Tulinius +11 more
2020Journal of Comparative Effectiveness Research94 citations Open access
Semantic Scholar
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
L. Conklin, Jesse M. Damsker, E. Hoffman, W. Jusko +28 more
2018Pharmacological Research93 citations Open access
Semantic Scholar
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
E. Hoffman, B. Schwartz, L. Mengle-Gaw, E. Smith +26 more
2019Neurology91 citations Open access
Semantic Scholar
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study
E. Smith, L. Conklin, E. Hoffman, P. Clemens +22 more
2020PLoS Medicine65 citations Open access
Semantic Scholar
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
C. McDonald, F. Muntoni, V. Penematsa, Joel Jiang +10 more
2021Journal of Comparative Effectiveness Research55 citations Open access
Semantic Scholar
Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies
C. Spurney, F. McCaffrey, A. Cnaan, L. Morgenroth +8 more
2015Journal of the American Society of Echocardiography53 citations Open access
Semantic Scholar
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children
Y. Hathout, L. Conklin, Haeri Seol, H. Gordish-Dressman +11 more
2016Scientific Reports52 citations Open access
Semantic Scholar
Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis
E. Mercuri, A. N. Osorio, F. Muntoni, F. Buccella +12 more
2023Journal of Neurology48 citations Open access
Semantic Scholar
Genetic modifiers of respiratory function in Duchenne muscular dystrophy
L. Bello, G. D'Angelo, Matteo Villa, Aurora Fusto +36 more
2020Annals of Clinical and Translational Neurology39 citations Open access
Semantic Scholar
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
S. Boca, M. Nishida, Michael Harris, Shruti Rao +11 more
2016PLoS ONE37 citations Open access
Semantic Scholar
Engaging Participants in Rare Disease Research: A Qualitative Study of Duchenne Muscular Dystrophy.
R. Bendixen, L. Morgenroth, K. Clinard
2016Clinical Therapeutics36 citations
Semantic Scholar
A multinational study on motor function in early-onset FSHD
J. Mah, Jia Feng, M. Jacobs, T. Duong +17 more
2018Neurology23 citations Open access
Semantic Scholar
Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy
F. Leigh, A. Ferlini, D. Biggar, K. Bushby +3 more
2018Pediatrics19 citations Open access
Semantic Scholar
The CINRG Becker Natural History Study: Baseline Characteristics
P. Clemens, G. Niizawa, Jia Feng, J. Florence +22 more
2020Muscle and Nerve18 citations Open access
Semantic Scholar
Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
S. Boca, M. Nishida, Michael Harris, Shruti Rao +14 more
2016PLoS ONE10 citations Open access
Semantic Scholar
Genetic modifiers of ambulation in the CINRG duchenne natural history study.
L. Bello, A. Kesari, H. Gordish-Dressman, A. Cnaan +7 more
20156 citations
Semantic Scholar
Genetic modifiers of upper limb function in Duchenne muscular dystrophy
Daniele Sabbatini, Aurora Fusto, S. Vianello, Matteo Villa +29 more
2022Journal of Neurology5 citations Open access
Semantic Scholar
The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy
L. Bello, Daniele Sabbatini, Aurora Fusto, Domenico Gorgoglione +34 more
2024Journal of Neuromuscular Diseases4 citations Open access
Semantic Scholar
Prednisone/prednisolone and deflazacort differ in long term outcomes on ambulation and side effects in the CINRG Duchenne Natural History Study (S50.001)
L. Bello, H. Gordish-Dressman, L. Morgenroth, E. Henricson +4 more
2015Neurology4 citations
Semantic Scholar
T.P.5.02 Pentoxifylline treatment fails to rescue muscle strength and function deterioration in prednisone-treated Duchenne muscular dystrophy (DMD)
D. Escolar, K. Gorni, A. Tesi-Rocha, J. Mah +16 more
20084 citations
Semantic Scholar
Ataluren Preserves Upper Limb Function in nmDMD Patients from Study 041, a Phase 3 Placebo-Controlled Trial, and the STRIDE Registry (S34.008)
C. McDonald, E. Mercuri, F. Muntoni, H. Gordish-Dressman +15 more
2023Wednesday, April 263 citations
Semantic Scholar
T.P.5.04 Randomized, double-blind, controlled study to compare efficacy and tolerability of standard daily prednisone regime with a novel intermittent high dose regime in ambulant boys with Duchenne muscular dystrophy
D. Escolar, Craig M. Mcdonald, A. Korengberg, Tulio E. Bertorini +15 more
20083 citations
Semantic Scholar
P.22 Age at loss of ambulation in patients with DMD from the STRIDE registry and the CINRG natural history study: A matched cohort analysis
E. Mercuri, F. Muntoni, F. Buccella, I. Desguerre +12 more
2022Neuromuscular Disorders2 citations
Semantic Scholar
Correction to: Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis
E. Mercuri, A. N. Osorio, F. Muntoni, F. Buccella +12 more
2023Journal of Neurology1 citations Open access
Semantic Scholar
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy
P. Spitali, I. Zaharieva, S. Bohringer, M. Hiller +58 more
2020European Journal of Human Genetics1 citations Open access
Semantic Scholar
Vision DMD: Vamorolone (VBP15) drug development program for Duchenne muscular dystrophy
Michela Guglieri, P. Clemens, A. Cnaan, J. Damsker +12 more
20171 citations Open access
Semantic Scholar
Integrating Genetic Modifier Genotype With Serum Proteomics in Duchenne Muscular Dystrophy Clinical Trials Links LTBP4 Genetic Modifier to IL-23/CD93 Pathways in Muscle.
Utkarsh J. Dang, Yuan Fang, D. Sabbatini, E. Pegoraro +13 more
2026American Journal of Medical Genetics. Part A0 citations Open access
Semantic Scholar
P.23 Pulmonary function in patients with Duchenne muscular dystrophy from the STRIDE Registry and CINRG Natural History Study: a matched cohort analysis
M. Tulinius, F. Buccella, I. Desguerre, J. Kirschner +12 more
2022Neuromuscular Disorders0 citations
Semantic Scholar
DMD – THERAPY
C. McDonald, F. Muntoni, M. Rance, J. Mcintosh +10 more
2020Neuromuscular Disorders0 citations
Semantic Scholar
Vision DMD: Vamorolone drug development program for Duchenne muscular dystrophy
M. Guglieri, P. Clemens, A. Cnaan, J. Damsker +8 more
20160 citations
Semantic Scholar
VISION – DMD: Drug development of VBP15, an experimental steroid-like drug for DMD
P. Clemens, M. Guglieri, A. Cnaan, J. Damsker +7 more
20150 citations
Semantic Scholar
Strategies for engaging the Duchenne muscular dystrophy community in research
P. R. Clemens, L. Morgenroth, K. Clinard, Roxanna M. Bendixen
20150 citations
Semantic Scholar
Patient Reported Quality of Life Measures in Limb-Girdle Muscular Dystrophy: Correlation with Clinical Outcomes (P4.118)
T. Duong, C. Tesi-Rocha, H. Gordish-Dressman, L. Morgenroth +2 more
2015Neurology0 citations
Semantic Scholar
G.P.13
J. Mah, Yi-Wen Chen, T. Duong, A. Cnaan +9 more
20140 citations
Semantic Scholar
Cyclicity (kap. 2 in Pullum (1979)) 3 Motivation 1 Für Das Zyklusprinzip: Ausschalten Von Alterna- Tiven Zum Zyklus
L. Morgenroth, A. Aßmann, Ñóöööòöóøøðð××óóóððñññðº Blockinóñ, Das Zyklusprinzip +1 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. McDonald×26
Invite
C. McDonald — researcher profile on SciRah
H. Gordish-Dressman×21
Invite
H. Gordish-Dressman — researcher profile on SciRah
E. Hoffman×16
Invite
E. Hoffman — researcher profile on SciRah
P. Clemens×14
Invite
P. Clemens — researcher profile on SciRah

×14

Invite

E. Henricson — researcher profile on SciRah

M. Tulinius×13

Invite

M. Tulinius — researcher profile on SciRah

Invite

J. Mah — researcher profile on SciRah

Invite

A. Cnaan — researcher profile on SciRah

Invite

L. Bello — researcher profile on SciRah

Invite

E. Mercuri — researcher profile on SciRah

P. Trifillis×8

Invite

P. Trifillis — researcher profile on SciRah

Invite

T. Duong — researcher profile on SciRah